|
I bought Masimo stock for $17 at the IPO years ago. Apple hired their engineers to develop the SPO2 monitoring in the newer watches. Masimo is introducing their own watch in 2024 that will be used more in patient monitoring than hipster wearing.
I know Joe Kiani the CEO pretty well and he developed the technology when he was at MIT. It's his "baby" and he doesn't want to sell it. Apple is hoping for a Presidential veto on the trade restriction that goes into effect 12/24.
Only problem is I was invited to a reception and fundraiser for said President held at Joe's home but politely declined. We'll see who has "the juice", Masimo or Apple.
There's a bit more but don't want to PARF up your thread Red.
__________________
---------------------------------------------------------------------------
"There is nothing to be learned from the second kick of a mule" - Mark Twain
|